DeepMed Research

CENTRE HENRI BECQUEREL

🇫🇷France

Country: 🇫🇷France

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid

Phase 2

Active, not recruiting

Conditions: Glioblastoma

Interventions: Other: Platelet level determination

First Posted Date: 2015-12-01

Last Posted Date: 2023-05-03

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 244

Registration Number: NCT02617745

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma

Phase 2

Completed

Conditions: Relapse
Thyroid Cancer

Interventions: Device: PET
Device: MRI imaging

First Posted Date: 2015-08-04

Last Posted Date: 2016-08-24

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 37

Registration Number: NCT02515084

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer

Phase 2

Conditions: Non-small Cell Lung Cancer

Interventions: Procedure: PET scan imaging

First Posted Date: 2015-07-24

Last Posted Date: 2018-07-23

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 80

Registration Number: NCT02507518

Locations: 🇫🇷
Centre hospitalier intercommunal Elbeuf Louviers, Elbeuf, France
🇫🇷
CH Dieppe, Dieppe, France
🇫🇷
CHU Rouen, Rouen, France

and more 2 locations

Study of the Angiogenesis by PET/CT in Patients With Lymphoma

Phase 2

Conditions: Lymphoma

Interventions: Device: RGD K5 PET scan

First Posted Date: 2015-07-07

Last Posted Date: 2018-07-11

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 25

Registration Number: NCT02490891

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Non-small Cell Lung Cancer

Interventions: Device: Miso PET scan
Device: FAZA PET scan

First Posted Date: 2015-07-07

Last Posted Date: 2020-07-30

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 23

Registration Number: NCT02490696

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC

Phase 2

Conditions: Non-small Cell Lung Cancer

Interventions: Radiation: No personalized dose redistribution
Radiation: Personalized dose redistribution

First Posted Date: 2015-06-16

Last Posted Date: 2016-07-28

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 150

Registration Number: NCT02473133

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Study of ESR1 Mutations in Metastatic Breast Cancer

Not Applicable

Completed

Conditions: Metastatic Breast Cancer

Interventions: Biological: Determination of ESR1 mutations

First Posted Date: 2015-06-16

Last Posted Date: 2020-07-30

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 104

Registration Number: NCT02473120

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy

Phase 3

Conditions: Bone Metastasis

Interventions: Drug: fentanyl transmucosal
Drug: Placebo

First Posted Date: 2015-04-27

Last Posted Date: 2018-07-23

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 120

Registration Number: NCT02426697

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

Not Applicable

Completed

Conditions: Non Hodgkin Lymphoma

Interventions: Other: next generation sequencing
Device: Fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET)

First Posted Date: 2015-01-15

Last Posted Date: 2017-07-07

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 30

Registration Number: NCT02339805

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer

Phase 2

Conditions: Early Stage Breast Carcinoma

Interventions: Device: Use of a PICC line for chemo administration (PowerPICC SOLO²)
Device: implanted port for chemo administration (X-port isp)

First Posted Date: 2014-03-26

Last Posted Date: 2018-07-24

Lead Sponsor: Centre Henri Becquerel

Target Recruit Count: 256

Registration Number: NCT02095743

Locations: 🇫🇷
Centre Henri Becquerel, Rouen, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy